Dudediligence.

Adaptive Biotechnologies Corporation

ADPTNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price
FilingsNewest: 10-Q, Quarterly reportAug 4 →InsidersNo open-market buys. 9 insiders sold $70.9M, 87 of 99 sales on a 10b5-1 plan.→HoldersViking Global Investors 18.9%BlackRock 9.5%Vanguard 4.0%→PeersClosest companies: GH, BDSX, CAI→

From the filings

Figures

Revenue
$308.1Mlast 12 months
Net income
−$63.9Mlast 12 months
Operating cash flow
−$27.0Mlast 12 months
Cash and equivalents
$169.9Mat the last balance sheet
Total debt
$0.00at the last balance sheet
Shares outstanding
159.1M shareson issue
Every year and quarter →